The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions
- PMID: 3469856
The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions
Abstract
This study presents data on 3,011 pleural and peritoneal effusion specimens that were examined over a three-year period (1982 to 1984). Totals of 812 (44%) of 1,846 pleural and 423 (36%) of 1,165 peritoneal specimens were positive for malignant cells. While 535 patients had malignant pleural effusions, 254 patients had malignant peritoneal effusions, and 57 had both malignant pleural and peritoneal effusions. The most common primary neoplasms causing malignant pleural effusions were carcinomas of breast (24%) and lung (19%) and lymphoreticular neoplasms (16%). The most common primary neoplasms causing malignant peritoneal effusions were carcinomas of ovary (32%) and breast (13%) and lymphoreticular neoplasms (7%). There was an average interval of more than 30 months between the histologic diagnosis of the primary neoplasm and the diagnosis of malignant effusions in patients with carcinoma of breast, lymphoreticular neoplasm and malignant melanoma. The average time until death following the diagnosis of a malignant effusions was five months or less, except for patients with carcinoma of the breast and carcinoma of the ovary. One hundred twenty-five patients (15%) presented with malignant effusions caused by neoplasms of unknown primary sites. The most common primary neoplasms that were later diagnosed were, in decreasing order of frequency, carcinoma of the ovary, carcinoma of the lung and lymphoreticular neoplasms.
Similar articles
-
The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.Acta Cytol. 1988 Mar-Apr;32(2):183-7. Acta Cytol. 1988. PMID: 3348059
-
Positive effusion cytology as the initial presentation of malignancy.Acta Cytol. 1987 Jul-Aug;31(4):448-52. Acta Cytol. 1987. PMID: 3604540
-
Malignant pleural effusions. A clinical cytopathologic study.Arch Intern Med. 1987 Jun;147(6):1133-6. Arch Intern Med. 1987. PMID: 3592878
-
Serous effusions in malignant lymphomas: a review.Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432. Diagn Cytopathol. 2006. PMID: 16604559 Review.
-
Effusion cytology.Clin Lab Med. 1991 Jun;11(2):443-67. Clin Lab Med. 1991. PMID: 1873966 Review.
Cited by
-
Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion.Thorac Cancer. 2016 Jul;7(4):393-8. doi: 10.1111/1759-7714.12354. Epub 2016 May 5. Thorac Cancer. 2016. PMID: 27385980 Free PMC article.
-
The importance of a satisfactory biopsy for the diagnosis of lung cancer in the era of personalized treatment.Curr Oncol. 2012 Jun;19(Suppl 1):S16-23. doi: 10.3747/co.19.1062. Curr Oncol. 2012. PMID: 22787407 Free PMC article.
-
Micronucleus and Its Significance in Effusion Fluids.J Cytol. 2020 Jan-Mar;37(1):58-61. doi: 10.4103/JOC.JOC_42_19. Epub 2019 Dec 23. J Cytol. 2020. PMID: 31942100 Free PMC article.
-
Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology.J Cytol. 2012 Jan;29(1):11-5. doi: 10.4103/0970-9371.93210. J Cytol. 2012. PMID: 22438610 Free PMC article.
-
Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials.J Thorac Dis. 2018 Jan;10(1):355-362. doi: 10.21037/jtd.2017.11.134. J Thorac Dis. 2018. PMID: 29600067 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources